Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.44 |
| ▸ | CNR2 | P34972 | 2/20 | 0.44 |
| ▸ | GLP1R | P43220 | 8/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14065642 | 0.94 | FAAH (0.45) | CNR1CNR2GLP1RFAAHNAAA | |
| SCHEMBL14065636 | 0.94 | GLP1R (0.46) | CNR1CNR2GLP1RFAAHNAAA | |
| SCHEMBL23378212 | 0.91 | CNR1 (0.50) | CNR1CNR2GLP1RGAAPTPN1 | |
| SCHEMBL14159308 | 0.91 | CNR1 (0.50) | CNR1CNR2GLP1RGAAPTPN1 | |
| SCHEMBL12013652 | 0.87 | GAA (0.50) | CNR1CNR2GAATSHRMEN1 | |
| SCHEMBL12013657 | 0.87 | GAA (0.50) | CNR1CNR2GAATSHRMEN1 | |
| SCHEMBL4270073 | 0.87 | GAA (0.50) | CNR1CNR2GAATSHRMEN1 | |
| SCHEMBL4263001 | 0.87 | GAA (0.50) | CNR1CNR2GAATSHRMEN1 | |
| SCHEMBL12013648 | 0.87 | GAA (0.50) | CNR1CNR2GAATSHRMEN1 | |
| SCHEMBL12013656 | 0.87 | TSHR (0.50) | CNR1CNR2GLP1RTSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2509566-B2 | PROCESS FOR PERMANENT SHAPING OF HUMAN HAIR | KAO GERMANY GMBH (DE) | 2022-03-09 | — | — | EP | disclosed |
| EP-2456412-B1 | COMPOSITION AND METHOD FOR COLOURING HAIR | KAO GERMANY GMBH (DE) | 2021-09-08 | — | — | EP | disclosed |
| EP-2346484-B1 | COMPOSITION FOR THE PERMANENT SHAPING OF HUMAN HAIR | KAO GERMANY GMBH (DE) | 2019-11-06 | — | — | EP | disclosed |
| EP-2670381-B1 | BLEACHING COMPOSITION | KAO GERMANY GMBH (DE) | 2018-03-28 | — | — | EP | disclosed |
| EP-2509567-B1 | PROCESS FOR OXIDATIVE COLOURING KERATIN FIBRES | KAO GERMANY GMBH (DE) | 2017-10-04 | — | — | EP | disclosed |
| US-9776021-B2 | Anhydrous dyeing composition and process for dyeing hair | KAO GERMANY GMBH (DE) | 2017-10-03 | — | — | US | disclosed |
| US-9737475-B2 | Anhydrous dyeing composition and process for dyeing hair | KAO GERMANY GMBH (DE) | 2017-08-22 | — | — | US | disclosed |
| EP-2151233-B1 | TWO-COMPONENT OXIDATIVE HAIR DYE COMPOSITION | KAO CORP (JP) | 2017-08-09 | — | — | EP | disclosed |
| EP-2547315-B1 | COLOURING COMPOSITION FOR KERATIN FIBRES | KAO GERMANY GMBH (DE) | 2017-07-05 | — | — | EP | disclosed |
| EP-2358441-B1 | BLEACHING/HIGHLIGHTING COMPOSITION | KAO GERMANY GMBH (DE) | 2017-06-14 | — | — | EP | disclosed |
| US-7419656-B2 | Mixture containing phenylenediamine compound | KAO CORPORATION (JP) | 2008-09-02 | — | — | US | disclosed |
| EP-1468666-B1 | Hair shampoo composition | KAO CORP (JP) | 2008-06-11 | — | — | EP | disclosed |
| US-7351716-B2 | Dermatological preparations | KAO CORPORATION (JP) | 2008-04-01 | — | — | US | disclosed |
| US-7351716-B2 | Dermatological preparations | KAO CORPORATION (JP) | 2008-04-01 | — | — | US | disclosed |
| US-20070166272-A1 | HAIR COSMETIC COMPOSITIONS AND PROCESS FOR PRODUCING THE SAME | KAO CORPORATION (JP) | 2007-07-19 | — | — | US | disclosed |
| US-20070166272-A1 | HAIR COSMETIC COMPOSITIONS AND PROCESS FOR PRODUCING THE SAME | KAO CORPORATION (JP) | 2007-07-19 | — | — | US | disclosed |
| WO-2007064042-A1 | AQUEOUS HAIR COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2007-06-07 | — | — | WO | disclosed |
| US-20070110692-A1 | HAIR STRAIGHTENER COMPOSITION | KAO CORPORATION (JP) | 2007-05-17 | — | — | US | disclosed |
| US-20070110692-A1 | HAIR STRAIGHTENER COMPOSITION | KAO CORPORATION (JP) | 2007-05-17 | — | — | US | disclosed |
| EP-1362574-B1 | Method of treating hair | KAO CORP (JP) | 2007-03-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070110692-A1 | HAIR STRAIGHTENER COMPOSITION | H1-10, H1-0, SHH | CNR1 1215/4885CNR2 1197/4885GLP1R 3065/4885 |
| US-20070166272-A1 | HAIR COSMETIC COMPOSITIONS AND PROCESS FOR PRODUCING THE SAME | CUTA, SHH, POLR1C | CNR1 1886/4885CNR2 2124/4885GLP1R 4722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.